Charles River Labs, the global CRO, will pay $27 million to acquire a 75% stake in Vital River, the largest supplier of laboratory animals in China. Charles River has the right to acquire the remaining 25% at a future date. As its name implies, Vital River has had a very close relationship with Charles River. For the past 10 years, it has been a licensee for production and distribution of Charles River’s disease models in China. More details.... Stock Symbol: (NYSE: CRL) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});